Paper511351
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
Ortengren B and 2 others. Infection, 1979. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim. Papers, record 511351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/511351
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfonamides | Major topic |
| Trimethoprim | Major topic |
| Urinary Tract Infections | Major topic |
| Drug Combinations | |
| Female | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Sulfadiazine | |
| Sulfamethoxazole |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4893676 | Progress in sulfonamide research. | Prog Drug Res | 1968 | https://conductscience.org/library/papers/4893676 | PubMed |
| 2 | 4901344 | Single-blind comparative trial of trimethoprim-sulphamethoxazole and ampicillin in the treatment of exacerbations of chronic bronchitis. | Br Med J | 1969 | https://conductscience.org/library/papers/4901344 | PubMed |
| 3 | 4669555 | Kidney transport in man of sulfamethoxazole and trimethoprim. | Chemotherapy | 1972 | https://conductscience.org/library/papers/4669555 | PubMed |
| 4 | 4148900 | Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli. | Zentralbl Bakteriol Orig A | 1973 | https://conductscience.org/library/papers/4148900 | PubMed |
| 5 | 4595634 | Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects. | Chemotherapy | 1973 | https://conductscience.org/library/papers/4595634 | PubMed |
| 6 | 5009465 | Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. | Chemotherapy | 1972 | https://conductscience.org/library/papers/5009465 | PubMed |
| 7 | 4463825 | Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. | Antibiot Chemother (1971) | 1974 | https://conductscience.org/library/papers/4463825 | PubMed |
| 8 | 4908562 | [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo]. | Chemotherapy | 1969 | https://conductscience.org/library/papers/4908562 | PubMed |
| 9 | 5057618 | Investigation of sulfonamide crystalluria in man. | Scand J Urol Nephrol | 1972 | https://conductscience.org/library/papers/5057618 | PubMed |
| 10 | 5325631 | The role of the therapeutic regimen in dosage design. II. | Chemotherapy | 1965 | https://conductscience.org/library/papers/5325631 | PubMed |
| 11 | 374276 | Antibacterial activity of co-trimazine in vitro and in vivo. | Infection | 1979 | https://conductscience.org/library/papers/374276 | PubMed |
| 12 | 4974510 | Trimethoprim in the treatment of urinary infections in hospital. | Br Med J | 1969 | https://conductscience.org/library/papers/4974510 | PubMed |
| 13 | 4571975 | The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole. | Chemotherapy | 1973 | https://conductscience.org/library/papers/4571975 | PubMed |
| 15 | 4412673 | Cross-over study of penicillin pharmacokinetics after intravenous infusions. | Chemotherapy | 1974 | https://conductscience.org/library/papers/4412673 | PubMed |
| 16 | 5514974 | Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat. | Chemotherapy | 1970 | https://conductscience.org/library/papers/5514974 | PubMed |
| 17 | 4958410 | The binding of antibiotics to serum proteins. | Br J Pharmacol Chemother | 1965 | https://conductscience.org/library/papers/4958410 | PubMed |
| 18 | 4640694 | Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination. | Acta Med Scand | 1972 | https://conductscience.org/library/papers/4640694 | PubMed |
| 19 | 5419724 | Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations. | Ann Med Exp Biol Fenn | 1970 | https://conductscience.org/library/papers/5419724 | PubMed |
| 20 | 1159621 | Elimination kinetics of sulfadiazine in patients with normal and impaired renal function. | J Pharmacokinet Biopharm | 1975 | https://conductscience.org/library/papers/1159621 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38172623 | The Vibrio cholerae CBASS phage defence system modulates resistance and killing by antifolate antibiotics. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/38172623 | PubMed |
| 33182761 | A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/33182761 | PubMed |
| 6759092 | Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. | Drugs | 1982 | https://conductscience.org/library/papers/6759092 | PubMed |
| 3536256 | Clinical pharmacokinetics of co-trimazine. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/3536256 | PubMed |
| 3052984 | Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3052984 | PubMed |
| 511355 | Trimethoprim/sulphonamide: concluding remarks. | Infection | 1979 | https://conductscience.org/library/papers/511355 | PubMed |
| 511352 | Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function. | Infection | 1979 | https://conductscience.org/library/papers/511352 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/511351
GET https://conductscience.org/api/papers/v1/511351/authors